A large de novo 9p21.3 deletion in a girl affected by astrocytoma and multiple melanoma

Simona Frigerio, Vittoria Disciglio, Siranoush Manoukian, Bernard Peissel, Gabriella Della Torre, Andrea Maurichi, Paola Collini, Barbara Pasini, Giacomo Gotti, Andrea Ferrari, Licia Rivoltini, Maura Massimino, Monica Rodolfo

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Association of melanoma, neural system tumors and germ line mutations at the 9p21 region in the CDKN2A, CDKN2B and CDKN2BAS genes has been reported in a small number of families worldwide and described as a discrete syndrome in melanoma families registered as a rare disease, the melanoma-astrocytoma syndrome.Case presentation: We here studied two young patients developing melanoma after radiotherapy for astrocytoma, both reporting lack of family history for melanoma or neural system tumors at genetic counselling. Patient A is a girl treated for anaplastic astrocytoma at 10 years and for multiple melanomas on the scalp associated to dysplastic nevi two years later. Her monozygotic twin sister carried dysplastic nevi and a slow growing, untreated cerebral lesion. Direct sequencing analysis showed no alterations in melanoma susceptibility genes including CDKN2A, CDK4, MC1R and MITF or in TP53. By microsatellite analysis, multiplex ligation-dependent probe amplification, and array comparative genomic hybridization a deletion including the CDKN2A, CDKN2B and CDKN2BAS gene cluster was detected in both twin sisters, encompassing a large region at 9p21.3 and occurring de novo after the loss of one paternal allele.Patient B is a boy of 7 years when treated for astrocytoma then developing melanoma associated to congenital nevi on the head 10 years later: sequencing and multiplex ligation-dependent probe amplification revealed a normal profile of the CDKN2A/CDKN2B/CDKN2BAS region. Array comparative genomic hybridization confirmed the absence of deletions at 9p21.3 and failed to reveal known pathogenic copy number variations.Conclusions: By comparison with the other germ line deletions at the CDKN2A, CDKN2B and CDKN2BAS gene cluster reported in melanoma susceptible families, the deletion detected in the two sisters is peculiar for its de novo origin and for its extension, as it represents the largest constitutive deletion at 9p21.3 region identified so far.In addition, the two studied cases add to other evidence indicating association of melanoma with exposure to ionizing radiation and with second neoplasm after childhood cancer. Melanoma should be considered in the monitoring of pigmented lesions in young cancer patients.

Original languageEnglish
Article number59
JournalBMC Medical Genetics
Volume15
Issue number1
DOIs
Publication statusPublished - May 17 2014

Fingerprint

Astrocytoma
Melanoma
Dysplastic Nevus Syndrome
Siblings
Comparative Genomic Hybridization
Multiplex Polymerase Chain Reaction
Multigene Family
Neoplasms
p16 Genes
Second Primary Neoplasms
Monozygotic Twins
Germ-Line Mutation
Nevus
Genetic Counseling
Rare Diseases
Ionizing Radiation
Scalp
Germ Cells
Microsatellite Repeats
Radiotherapy

Keywords

  • 9p21.3 deletion
  • CDKN2A
  • CDKN2BAS
  • Melanoma-astrocytoma syndrome
  • MLPA
  • Oligo array-CGH

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

A large de novo 9p21.3 deletion in a girl affected by astrocytoma and multiple melanoma. / Frigerio, Simona; Disciglio, Vittoria; Manoukian, Siranoush; Peissel, Bernard; Della Torre, Gabriella; Maurichi, Andrea; Collini, Paola; Pasini, Barbara; Gotti, Giacomo; Ferrari, Andrea; Rivoltini, Licia; Massimino, Maura; Rodolfo, Monica.

In: BMC Medical Genetics, Vol. 15, No. 1, 59, 17.05.2014.

Research output: Contribution to journalArticle

@article{b3ac5c53d5e24566854045242e3f15b6,
title = "A large de novo 9p21.3 deletion in a girl affected by astrocytoma and multiple melanoma",
abstract = "Background: Association of melanoma, neural system tumors and germ line mutations at the 9p21 region in the CDKN2A, CDKN2B and CDKN2BAS genes has been reported in a small number of families worldwide and described as a discrete syndrome in melanoma families registered as a rare disease, the melanoma-astrocytoma syndrome.Case presentation: We here studied two young patients developing melanoma after radiotherapy for astrocytoma, both reporting lack of family history for melanoma or neural system tumors at genetic counselling. Patient A is a girl treated for anaplastic astrocytoma at 10 years and for multiple melanomas on the scalp associated to dysplastic nevi two years later. Her monozygotic twin sister carried dysplastic nevi and a slow growing, untreated cerebral lesion. Direct sequencing analysis showed no alterations in melanoma susceptibility genes including CDKN2A, CDK4, MC1R and MITF or in TP53. By microsatellite analysis, multiplex ligation-dependent probe amplification, and array comparative genomic hybridization a deletion including the CDKN2A, CDKN2B and CDKN2BAS gene cluster was detected in both twin sisters, encompassing a large region at 9p21.3 and occurring de novo after the loss of one paternal allele.Patient B is a boy of 7 years when treated for astrocytoma then developing melanoma associated to congenital nevi on the head 10 years later: sequencing and multiplex ligation-dependent probe amplification revealed a normal profile of the CDKN2A/CDKN2B/CDKN2BAS region. Array comparative genomic hybridization confirmed the absence of deletions at 9p21.3 and failed to reveal known pathogenic copy number variations.Conclusions: By comparison with the other germ line deletions at the CDKN2A, CDKN2B and CDKN2BAS gene cluster reported in melanoma susceptible families, the deletion detected in the two sisters is peculiar for its de novo origin and for its extension, as it represents the largest constitutive deletion at 9p21.3 region identified so far.In addition, the two studied cases add to other evidence indicating association of melanoma with exposure to ionizing radiation and with second neoplasm after childhood cancer. Melanoma should be considered in the monitoring of pigmented lesions in young cancer patients.",
keywords = "9p21.3 deletion, CDKN2A, CDKN2BAS, Melanoma-astrocytoma syndrome, MLPA, Oligo array-CGH",
author = "Simona Frigerio and Vittoria Disciglio and Siranoush Manoukian and Bernard Peissel and {Della Torre}, Gabriella and Andrea Maurichi and Paola Collini and Barbara Pasini and Giacomo Gotti and Andrea Ferrari and Licia Rivoltini and Maura Massimino and Monica Rodolfo",
year = "2014",
month = "5",
day = "17",
doi = "10.1186/1471-2350-15-59",
language = "English",
volume = "15",
journal = "BMC Medical Genetics",
issn = "1471-2350",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - A large de novo 9p21.3 deletion in a girl affected by astrocytoma and multiple melanoma

AU - Frigerio, Simona

AU - Disciglio, Vittoria

AU - Manoukian, Siranoush

AU - Peissel, Bernard

AU - Della Torre, Gabriella

AU - Maurichi, Andrea

AU - Collini, Paola

AU - Pasini, Barbara

AU - Gotti, Giacomo

AU - Ferrari, Andrea

AU - Rivoltini, Licia

AU - Massimino, Maura

AU - Rodolfo, Monica

PY - 2014/5/17

Y1 - 2014/5/17

N2 - Background: Association of melanoma, neural system tumors and germ line mutations at the 9p21 region in the CDKN2A, CDKN2B and CDKN2BAS genes has been reported in a small number of families worldwide and described as a discrete syndrome in melanoma families registered as a rare disease, the melanoma-astrocytoma syndrome.Case presentation: We here studied two young patients developing melanoma after radiotherapy for astrocytoma, both reporting lack of family history for melanoma or neural system tumors at genetic counselling. Patient A is a girl treated for anaplastic astrocytoma at 10 years and for multiple melanomas on the scalp associated to dysplastic nevi two years later. Her monozygotic twin sister carried dysplastic nevi and a slow growing, untreated cerebral lesion. Direct sequencing analysis showed no alterations in melanoma susceptibility genes including CDKN2A, CDK4, MC1R and MITF or in TP53. By microsatellite analysis, multiplex ligation-dependent probe amplification, and array comparative genomic hybridization a deletion including the CDKN2A, CDKN2B and CDKN2BAS gene cluster was detected in both twin sisters, encompassing a large region at 9p21.3 and occurring de novo after the loss of one paternal allele.Patient B is a boy of 7 years when treated for astrocytoma then developing melanoma associated to congenital nevi on the head 10 years later: sequencing and multiplex ligation-dependent probe amplification revealed a normal profile of the CDKN2A/CDKN2B/CDKN2BAS region. Array comparative genomic hybridization confirmed the absence of deletions at 9p21.3 and failed to reveal known pathogenic copy number variations.Conclusions: By comparison with the other germ line deletions at the CDKN2A, CDKN2B and CDKN2BAS gene cluster reported in melanoma susceptible families, the deletion detected in the two sisters is peculiar for its de novo origin and for its extension, as it represents the largest constitutive deletion at 9p21.3 region identified so far.In addition, the two studied cases add to other evidence indicating association of melanoma with exposure to ionizing radiation and with second neoplasm after childhood cancer. Melanoma should be considered in the monitoring of pigmented lesions in young cancer patients.

AB - Background: Association of melanoma, neural system tumors and germ line mutations at the 9p21 region in the CDKN2A, CDKN2B and CDKN2BAS genes has been reported in a small number of families worldwide and described as a discrete syndrome in melanoma families registered as a rare disease, the melanoma-astrocytoma syndrome.Case presentation: We here studied two young patients developing melanoma after radiotherapy for astrocytoma, both reporting lack of family history for melanoma or neural system tumors at genetic counselling. Patient A is a girl treated for anaplastic astrocytoma at 10 years and for multiple melanomas on the scalp associated to dysplastic nevi two years later. Her monozygotic twin sister carried dysplastic nevi and a slow growing, untreated cerebral lesion. Direct sequencing analysis showed no alterations in melanoma susceptibility genes including CDKN2A, CDK4, MC1R and MITF or in TP53. By microsatellite analysis, multiplex ligation-dependent probe amplification, and array comparative genomic hybridization a deletion including the CDKN2A, CDKN2B and CDKN2BAS gene cluster was detected in both twin sisters, encompassing a large region at 9p21.3 and occurring de novo after the loss of one paternal allele.Patient B is a boy of 7 years when treated for astrocytoma then developing melanoma associated to congenital nevi on the head 10 years later: sequencing and multiplex ligation-dependent probe amplification revealed a normal profile of the CDKN2A/CDKN2B/CDKN2BAS region. Array comparative genomic hybridization confirmed the absence of deletions at 9p21.3 and failed to reveal known pathogenic copy number variations.Conclusions: By comparison with the other germ line deletions at the CDKN2A, CDKN2B and CDKN2BAS gene cluster reported in melanoma susceptible families, the deletion detected in the two sisters is peculiar for its de novo origin and for its extension, as it represents the largest constitutive deletion at 9p21.3 region identified so far.In addition, the two studied cases add to other evidence indicating association of melanoma with exposure to ionizing radiation and with second neoplasm after childhood cancer. Melanoma should be considered in the monitoring of pigmented lesions in young cancer patients.

KW - 9p21.3 deletion

KW - CDKN2A

KW - CDKN2BAS

KW - Melanoma-astrocytoma syndrome

KW - MLPA

KW - Oligo array-CGH

UR - http://www.scopus.com/inward/record.url?scp=84901603899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901603899&partnerID=8YFLogxK

U2 - 10.1186/1471-2350-15-59

DO - 10.1186/1471-2350-15-59

M3 - Article

C2 - 24884915

AN - SCOPUS:84901603899

VL - 15

JO - BMC Medical Genetics

JF - BMC Medical Genetics

SN - 1471-2350

IS - 1

M1 - 59

ER -